Neues in der konservativen Therapie bei Arthrosen großer Gelenke
作者： Ernst Wagner
DOI: 10.1007/S10354-008-0603-2
关键词:
摘要: A large number of treatment options exist for osteoarthritis the knee and hip. The choice therapy depends on clinical symptomatology, preexisting risk factors (e.g. obesity), disease stage. This review includes novel aspects symptomatic conservative (physical medicine drugs), especially pain management (electrotherapy), rehabilitational aspects. Rehabilitation is essential, as a chronic condition, that requires lifelong intervention, causal cure has not been identified yet. New hyaluronic acid, slow-acting drugs in (chondroitin sulfate, glucosamine diacerein), experimental drugs, which claim properties modification (bisphosphonates, calcitonin, interleukin-1 antagonists), are discussed.
springer.com
sci-hub.se 参考文章(65)
Tim D Spector, Philip G Conaghan, J Christopher Buckland-Wright, Patrick Garnero, Gary A Cline, John F Beary, David J Valent, Joan M Meyer, Effect of risedronate on joint structure and symptoms of knee osteoarthritis: results of the BRISK randomized, controlled trial [ISRCTN01928173] Arthritis Research & Therapy. ,vol. 7, pp. 1- 9 ,(2005) , 10.1186/AR1716
Manathip Osiri, Vivian Welch, Lucie Brosseau, Beverley Shea, J McGowan, Peter Tugwell, G Wells, None, Transcutaneous electrical nerve stimulation for knee osteoarthritis. Cochrane Database of Systematic Reviews. ,(2000) , 10.1002/14651858.CD002823
Jill Hayden, Maurits W Van Tulder, Antti Malmivaara, Bart W Koes, None, Exercise therapy for treatment of non-specific low back pain. Cochrane Database of Systematic Reviews. pp. 0- 0 ,(2005) , 10.1002/14651858.CD000335.PUB2
M. A. KARSDAL, B. C. SONDERGAARD, M. ARNOLD, C. CHRISTIANSEN, Calcitonin affects both bone and cartilage: a dual action treatment for osteoarthritis? Annals of the New York Academy of Sciences. ,vol. 1117, pp. 181- 195 ,(2007) , 10.1196/ANNALS.1402.041
B.C. Sondergaard, H. Wulf, K. Henriksen, S. Schaller, S. Oestergaard, P. Qvist, L.B. Tankó, Y.Z. Bagger, C. Christiansen, M.A. Karsdal, Calcitonin directly attenuates collagen type II degradation by inhibition of matrix metalloproteinase expression and activity in articular chondrocytes. Osteoarthritis and Cartilage. ,vol. 14, pp. 759- 768 ,(2006) , 10.1016/J.JOCA.2006.01.014
Elizabeth W Karlson, Lisa A Mandl, Gideon N Aweh, Oliver Sangha, Matthew H Liang, Francine Grodstein, Total hip replacement due to osteoarthritis: the importance of age, obesity, and other modifiable risk factors The American Journal of Medicine. ,vol. 114, pp. 93- 98 ,(2003) , 10.1016/S0002-9343(02)01447-X
K. Vuolteenaho, T. Moilanen, R. G. Knowles, E. Moilanen, The role of nitric oxide in osteoarthritis Scandinavian Journal of Rheumatology. ,vol. 36, pp. 247- 258 ,(2007) , 10.1080/03009740701483014
Leena Sharma, Congrong Lou, September Cahue, Dorothy D. Dunlop, The mechanism of the effect of obesity in knee osteoarthritis: The mediating role of malalignment Arthritis & Rheumatism. ,vol. 43, pp. 568- 575 ,(2000) , 10.1002/1529-0131(200003)43:3<568::AID-ANR13>3.0.CO;2-E
E.N. Blaney Davidson, P.M. van der Kraan, W.B. van den Berg, TGF-β and osteoarthritis Osteoarthritis and Cartilage. ,vol. 15, pp. 597- 604 ,(2007) , 10.1016/J.JOCA.2007.02.005
Daniel-Henri Manicourt, Moïse Azria, Linda Mindeholm, Eugene J.-M. Thonar, Jean-Pierre Devogelaer, Oral salmon calcitonin reduces Lequesne's algofunctional index scores and decreases urinary and serum levels of biomarkers of joint metabolism in knee osteoarthritis Arthritis & Rheumatism. ,vol. 54, pp. 3205- 3211 ,(2006) , 10.1002/ART.22075